MAP2K7 and cancer: Specifically, MEK/ERK inhibitors were found to reduce the expression of cachectic cytokines produced by cancer cells105,106, independently from reduction in cancer growth, which can also occur in response to administration of MEK/ERK inhibitors105,106.